These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 34322151)

  • 21. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
    Liu L; Liang L; Mai G; Chen Y
    FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
    Zhang P; Liu G; Lu L
    Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 26. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.
    Xu C; Liu Y; Zhang Y; Gao L
    Front Genet; 2022; 13():928105. PubMed ID: 36313449
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
    Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.
    Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J
    Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma.
    Liu J; Jiang C; Xu C; Wang D; Shen Y; Liu Y; Gu L
    Cancer Cell Int; 2021 Feb; 21(1):101. PubMed ID: 33579281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma.
    Pan S; Tang T; Wu Y; Zhang L; Song Z; Yu S
    Front Genet; 2021; 12():778153. PubMed ID: 35047006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma.
    Zhang Z; Zhu H; Li Q; Gao W; Zang D; Su W; Yang R; Zhong J
    Front Genet; 2021; 12():647152. PubMed ID: 34589110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
    Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
    PeerJ; 2023; 11():e16477. PubMed ID: 38025763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer.
    Cao L; Li T; Ba Y; Chen E; Yang J; Zhang H
    Front Genet; 2022; 13():801484. PubMed ID: 35281839
    [No Abstract]   [Full Text] [Related]  

  • 40. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.